scorecardresearch
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals

 

More Stories on Glenmark Pharmaceuticals
Glenmark Life Sciences registered revenue from operations of Rs 524.9 crore in Q1 FY22

Glenmark Life Sciences Q1 profit rises to Rs 100.9 cr; revenue up 32.2%

Aug 13, 2021

Revenues from generic API segment increased 38.3% YoY to Rs 4,803 crore during Q1, driven by growth across all geographies

Glenmark Life Sciences filed for an updated DRHP last week

Glenmark Life Sciences’ Rs 1,600-cr IPO may open next week

Jul 19, 2021

Glenmark Life Sciences’ IPO comprises a fresh issue of Rs 1,160 crore and a sale of 7.3 million shares by promoter Glenmark Pharmaceuticals

Stocks in news: Mahindra & Mahindra, Fortis Healthcare, Sundaram Finance, Bank of Baroda, Glenmark Pharmaceuticals, Divi's Labs and more

Stocks in news: M&M, Fortis Healthcare, Sundaram Finance, Bank of Baroda and more

May 31, 2021

Stocks in news: Mahindra & Mahindra, Fortis Healthcare, Sundaram Finance, Bank of Baroda, Glenmark Pharmaceuticals, Divi's Labs and more

Stocks in news: Sun Pharma, TCS, Eicher Motors, NLC India, UCO Bank and more

Stocks in news: Sun Pharma, TCS, Eicher Motors, UCO Bank and more

May 28, 2021

Stocks in news: Sun Pharma, TCS, Eicher Motors, NLC India, UCO Bank, NLC India, Navneet Education, Dixon Technologies and more

The offer comprises fresh issue of up to Rs 1,160 crore and an offer for sale of up to 73,05,245 equity shares of Rs 2 each of Glenmark Life Sciences Ltd

Glenmark Pharma arm files paperwork for IPO with SEBI

Apr 17, 2021

Glenmark Life Sciences has filed a Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (Sebi) for an initial public offer, according to a regulatory filing

Representational Image (Photo-Reuters)

Glenmark Q3 results: Net profit rises by 30% to Rs 248 crore

Feb 13, 2021

The company had posted a net profit of Rs 190.83 crore for the corresponding period of the previous fiscal, Glenmark Pharmaceuticals said in a regulatory filing

The Phase 3 study with antiviral drug Favipiravir, brand name FabiFlu®, was conducted in 150 patients as part of a randomised, open label, multicenter, Phase 3 study

COVID-19: Favipiravir's treatment benefits uncovered in new study

Nov 23, 2020

The study found that patients of confirmed COVID-19 with moderate symptoms were discharged from hospital earlier than those patients that did not receive Favipiravir, with the median time to clinical cure reduced by 2.5 days compared with the control group.

Nindanib was developed by Boehringer Ingelheim and received U.S. Food and Drug Administration (FDA) approval for use for idiopathic pulmonary fibrosis in 2014

Glenmark launches medicine for pulmonary fibrosis at Rs 4,500 per month

Oct 14, 2020

The indicated price is for treatment using the drug for about a month, or a treatment cycle depending on the disease progression and patient condition

The capsules are used in the treatment of adult patients with relapsing forms of multiple sclerosis

Glenmark gets final USFDA approval for Fingolimod capsules

Jun 19, 2020

Glenmark's current portfolio consists of 164 products authorised for distribution in the US marketplace and 44 abbreviated new drug applications pending approval with the USFDA

Glenmark Pharma stock is trading higher than 5 day, 20 day, 50 day, 100 day and 200 day moving averages.

Glenmark Pharma share rises 7% on strong Q1 earnings

Aug 17, 2020

Glenmark Pharma share opened with a gain of 4.14% today

Stocks to watch out for today: Companies set to announce their earnings are RIL, HDFC, Lakshmi Vilas Bank and Torrent Pharma among others.

Stocks in news: Bharti Airtel, YES Bank, PVR, Inox Leisure, CEAT and more

Jul 30, 2020

Stocks to watch out for today on July 30: Bharti Airtel, YES Bank, PVR, Inox Leisure, CEAT among others are the top stocks to watch out for in Thursday's  trading session